المؤلفون: Terry, MB, Liao, Y, Kast, K, Antoniou, AC, McDonald, JA, Mooij, TM, Engel, C, Nogues, C, Buecher, B, Mari, V, Moretta-Serra, J, Gladieff, L, Luporsi, E, Barrowdale, D, Frost, D, Henderson, A, Brewer, C, Evans, DG, Eccles, D, Cook, J, Ong, K-R, Izatt, L, Ahmed, M, Morrison, PJ, Dommering, CJ, Oosterwijk, JC, Ausems, MGEM, Kriege, M, Buys, SS, Andrulis, IL, John, EM, Daly, M, Friedlander, M, McLachlan, SA, Osorio, A, Caldes, T, Jakubowska, A, Simard, J, Singer, CF, Tan, Y, Olah, E, Navratilova, M, Foretova, L, Gerdes, A-M, Roos-Blom, M-J, Arver, B, Olsson, H, Schmutzler, RK, Hopper, JL, van Leeuwen, FE, Goldgar, D, Milne, RL, Easton, DF, Rookus, MA, Andrieu, N, EMBRACE, GENEPSO, BCFR, HEBON, kConFab and IBCCS

مصطلحات موضوعية: endocrine system diseases, skin and connective tissue diseases

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::10bee1903a17dfc510757c19cd2116b9
https://openaccess.sgul.ac.uk/id/eprint/111615/1/pky078.pdf

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Dommering, CJ, Garvelink, MM, Moll, AC, van Dijk, J, Imhof, SM, Meijers-Heijboer, H, Henneman, L

المصدر: Clinical Genetics; Mar2012, Vol. 81 Issue 3, p216-223, 8p, 5 Charts

مصطلحات موضوعية: HUMAN reproduction, HIGH-risk pregnancy, RETINOBLASTOMA, MEDICAL genetics, PRENATAL diagnosis, CROSS-sectional method

مصطلحات جغرافية: NETHERLANDS

المؤلفون: Dommering, CJ, van den Heuvel, MR, Moll, AC, Imhof, SM, Meijers-Heijboer, H, Henneman, L

المصدر: Clinical Genetics; Oct2010, Vol. 78 Issue 4, p334-341, 8p, 1 Chart

مصطلحات موضوعية: DECISION making, GENETIC counseling, QUALITATIVE research, PRENATAL diagnosis, ANTIBODY diversity, RETINOBLASTOMA, RETINA cancer, CANCER risk factors, PATIENTS

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: van Barele M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Akdeniz D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Andrieu N; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; PSL Research University, Paris, France.; Mines ParisTech, Fontainebleau, France., Noguès C; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France.; Institut Paoli-Calmettes & Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands., Wevers M; Department for Clinical Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands., Ausems MGEM; Division of Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands., de Bock GH; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Dommering CJ; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Gómez-García EB; Department of Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands., van Leeuwen FE; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Mooij TM; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Evans DG; The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, Manchester, UK., Izatt L; Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Tischkowitz M; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada., Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Brewer C; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Quebec City, QC, Canada., Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Centre for Personalized Response Monitoring in Oncology (PREMIO), Odense University Hospital, Odense, Denmark., Kast K; Center of Familial Breast and Ovarian Cancer and Center of Integrated Oncology, University Hospital Cologne, Cologne, Germany., Rhiem K; Center of Familial Breast and Ovarian Cancer and Center of Integrated Oncology, University Hospital Cologne, Cologne, Germany., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., de la Hoya M; Molecular Oncology Laboratory, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Foretová L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Sattler MGA; Department of Radiotherapy, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Schmidt MK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

مؤلفون مشاركون: Genepso, HEBON, EMBRACE

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Nov 08; Vol. 115 (11), pp. 1318-1328.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/radiotherapy , Breast Neoplasms*/drug therapy, Humans ; Female ; BRCA1 Protein/genetics ; Cohort Studies ; Prospective Studies ; BRCA2 Protein/genetics

المؤلفون: Jansen RW; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., de Bloeme CM; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Cardoen L; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Göricke S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., van Elst S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Jessen JL; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Ramasubramanian A; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Skalet AH; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Miller AK; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Maeder P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Uner OE; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Hubbard GB; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Grossniklaus H; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Boldt HC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Nichols KE; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Brennan RC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Sen S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Sirin S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Brisse HJ; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Galluzzi P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Dommering CJ; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Castelijns JA; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., van der Valk P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Boellaard R; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Dorsman J; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Moll AC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., de Jong MC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., de Graaf P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.).

المصدر: Radiology [Radiology] 2023 Jun; Vol. 307 (5), pp. e222264. Date of Electronic Publication: 2023 May 16.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Radiological Society of North America Country of Publication: United States NLM ID: 0401260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-1315 (Electronic) Linking ISSN: 00338419 NLM ISO Abbreviation: Radiology Subsets: MEDLINE

مواضيع طبية MeSH: Retinoblastoma*/diagnostic imaging , Retinoblastoma*/genetics , Retinal Neoplasms*/diagnostic imaging , Retinal Neoplasms*/genetics, Humans ; N-Myc Proto-Oncogene Protein/genetics ; Retrospective Studies ; Case-Control Studies ; Ubiquitin-Protein Ligases/genetics ; Retinoblastoma Binding Proteins/genetics

المؤلفون: Bakhuizen JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Hopman SMJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Bosscha MI; Department of Ophthalmology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Dommering CJ; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center-Wilhelmina Children's Hospital, Utrecht, the Netherlands., Hol JA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kester LA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koudijs MJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Loeffen JLC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Moll AC; Department of Ophthalmology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Smetsers SE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Vos-Kerkhof E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jongmans MCJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

المصدر: JAMA network open [JAMA Netw Open] 2023 Feb 01; Vol. 6 (2), pp. e2254157. Date of Electronic Publication: 2023 Feb 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Neurofibromatosis 1*, Humans ; Cohort Studies ; Retrospective Studies ; Disease Susceptibility ; Genotype

المؤلفون: Schoenaker MHD; Department of Pediatric Neurology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands; Laboratory for Immunology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: m.h.d.schoenaker@lumc.nl., Takada S; Laboratory for Immunology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands., van Deuren M; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Dommering CJ; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, HV Amsterdam, the Netherlands., Henriët SSV; Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands., Pico I; Laboratory for Immunology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands., Vogel WV; Department of Radiation Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Department of Nuclear Medicine, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Weemaes CMR; Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands., Willemsen MAAP; Department of Pediatric Neurology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands., van der Burg M; Laboratory for Immunology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands., Kaanders JHAM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

المصدر: European journal of medical genetics [Eur J Med Genet] 2021 Oct; Vol. 64 (10), pp. 104293. Date of Electronic Publication: 2021 Aug 02.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101247089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0849 (Electronic) Linking ISSN: 17697212 NLM ISO Abbreviation: Eur J Med Genet Subsets: MEDLINE

مواضيع طبية MeSH: Bloom Syndrome/*complications , Carcinoma/*radiotherapy , Radiotherapy/*adverse effects, Adult ; Bloom Syndrome/genetics ; Carcinoma/complications ; Cells, Cultured ; DNA Breaks, Double-Stranded ; DNA Repair ; Female ; Fibroblasts/radiation effects ; Humans ; Male ; Middle Aged ; Radiation Tolerance ; RecQ Helicases/genetics